CenterBook Partners
CYTK icon

CenterBook Partners’s Cytokinetics CYTK Stock Holding History

CenterBook Partners’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.4M Buy
21,233
+13,474
+174% +$1.03M 0.06% 373
2026
Q2 		$661K Sell
7,759
-105
-1% -$7.54K 0.03% 458
2026
Q1 		$518K Buy
+7,864
New +$500K 0.03% 480
2024
Q3 		– Sell
-16,896
Closed -$915K – 472
2024
Q2 		$915K Buy
+16,896
New +$1.02M 0.06% 339

Other funds holding CYTK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

CenterBook Partners's CYTK Position: Q3 2026 in Review

CenterBook Partners increased its Cytokinetics (CYTK) stake by 174% in Q3 2026, buying an estimated $1.03M and bringing the position to 21,233 shares worth $1.4M. The position accounts for 0.06% of the portfolio, ranked #373.

CenterBook Partners first reported a position in CYTK in Q2 2024 and has held it in 4 quarters since. 226 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • CenterBook Partners held 21,233 shares of Cytokinetics worth $1.4M as of Q3 2026.
  • CenterBook Partners bought 13,474 Cytokinetics shares in Q3 2026, an estimated $1.03M.
  • Cytokinetics made up 0.06% of CenterBook Partners's portfolio in Q3 2026, its #373 holding.
  • CenterBook Partners first reported a position in Cytokinetics in Q2 2024 and has held it in 4 quarters since.
  • 226 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.